ATE338057T1 - Peptidderivat, pharmazeutisch unbedenkliches salz davon, verfahren zu dessen herstellung und dessen verwendung - Google Patents
Peptidderivat, pharmazeutisch unbedenkliches salz davon, verfahren zu dessen herstellung und dessen verwendungInfo
- Publication number
- ATE338057T1 ATE338057T1 AT02780081T AT02780081T ATE338057T1 AT E338057 T1 ATE338057 T1 AT E338057T1 AT 02780081 T AT02780081 T AT 02780081T AT 02780081 T AT02780081 T AT 02780081T AT E338057 T1 ATE338057 T1 AT E338057T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- pharmaceutically acceptable
- acceptable salt
- peptide derivative
- production
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- 125000006239 protecting group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 239000004475 Arginine Substances 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000004472 Lysine Substances 0.000 abstract 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/30—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to nitro or nitroso groups
- C07C279/32—N-nitroguanidines
- C07C279/36—Substituted N-nitroguanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001352012 | 2001-11-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE338057T1 true ATE338057T1 (de) | 2006-09-15 |
Family
ID=19164244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02780081T ATE338057T1 (de) | 2001-11-16 | 2002-11-14 | Peptidderivat, pharmazeutisch unbedenkliches salz davon, verfahren zu dessen herstellung und dessen verwendung |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7067476B2 (de) |
| EP (1) | EP1445262B1 (de) |
| JP (1) | JP4006598B2 (de) |
| KR (1) | KR100603948B1 (de) |
| CN (1) | CN1274712C (de) |
| AT (1) | ATE338057T1 (de) |
| AU (1) | AU2002343783B2 (de) |
| CA (1) | CA2465080A1 (de) |
| DE (1) | DE60214414T2 (de) |
| WO (1) | WO2003042237A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101260086B (zh) * | 2007-03-06 | 2011-08-10 | 中国科学院上海药物研究所 | 蛋白酪氨酸磷酸酯酶1b抑制剂及其制备方法和用途 |
| JP5397851B2 (ja) * | 2009-05-21 | 2014-01-22 | Ｎｓマテリアルズ株式会社 | ペプチド誘導体又はその塩の製造方法 |
| WO2017201322A1 (en) * | 2016-05-19 | 2017-11-23 | Cortexyme, Inc. | Treatment of osteoarthritis with gingipain blocking agents |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0597708A (ja) | 1991-10-02 | 1993-04-20 | Lion Corp | 歯周病治療剤 |
| JPH11139947A (ja) | 1997-11-11 | 1999-05-25 | Sunstar Inc | マトリックスメタロプロテアーゼ阻害剤含有口腔用組成物 |
| JP3873429B2 (ja) | 1998-02-20 | 2007-01-24 | 大鵬薬品工業株式会社 | ペプチド誘導体及びその薬学的に許容される塩、その製造方法及びその用途 |
| JPH11335274A (ja) | 1998-03-20 | 1999-12-07 | Sagami Chem Res Center | アルギンギパイン阻害剤、歯周病菌生育阻害剤および抗歯周病剤 |
| JP2000191487A (ja) | 1998-12-29 | 2000-07-11 | Sunstar Inc | マトリクスメタロプロテア―ゼ阻害用口腔剤組成物及び飲食品組成物 |
| US6951843B2 (en) | 2000-11-06 | 2005-10-04 | Taiho Pharmaceutical Co., Ltd. | Peptide derivatives and their pharmaceutically acceptable salts, thereof, processes for preparation of both and use thereof |
-
2002
- 2002-11-14 CA CA002465080A patent/CA2465080A1/en not_active Abandoned
- 2002-11-14 DE DE60214414T patent/DE60214414T2/de not_active Expired - Lifetime
- 2002-11-14 US US10/493,060 patent/US7067476B2/en not_active Expired - Fee Related
- 2002-11-14 EP EP02780081A patent/EP1445262B1/de not_active Expired - Lifetime
- 2002-11-14 CN CNB02822647XA patent/CN1274712C/zh not_active Expired - Fee Related
- 2002-11-14 WO PCT/JP2002/011860 patent/WO2003042237A1/ja active IP Right Grant
- 2002-11-14 KR KR1020047007284A patent/KR100603948B1/ko not_active IP Right Cessation
- 2002-11-14 AT AT02780081T patent/ATE338057T1/de not_active IP Right Cessation
- 2002-11-14 JP JP2003544072A patent/JP4006598B2/ja not_active Expired - Fee Related
- 2002-11-14 AU AU2002343783A patent/AU2002343783B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP1445262A4 (de) | 2005-06-15 |
| DE60214414D1 (de) | 2006-10-12 |
| CN1274712C (zh) | 2006-09-13 |
| KR100603948B1 (ko) | 2006-07-24 |
| CA2465080A1 (en) | 2003-05-22 |
| DE60214414T2 (de) | 2007-02-22 |
| JP4006598B2 (ja) | 2007-11-14 |
| CN1622953A (zh) | 2005-06-01 |
| EP1445262A8 (de) | 2004-10-27 |
| KR20050044448A (ko) | 2005-05-12 |
| WO2003042237A1 (fr) | 2003-05-22 |
| EP1445262B1 (de) | 2006-08-30 |
| AU2002343783B2 (en) | 2007-01-18 |
| US7067476B2 (en) | 2006-06-27 |
| EP1445262A1 (de) | 2004-08-11 |
| JPWO2003042237A1 (ja) | 2005-03-10 |
| US20040214780A1 (en) | 2004-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1051500A1 (en) | Cell adhesion inhibitors | |
| AU699008B2 (en) | Aminothiazole derivative, medicament containing the same, and intermediate for preperation of said compound | |
| DE69820248D1 (de) | Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben | |
| IL150650A0 (en) | Piperidine derivatives and pharmaceutical compositions containing the same | |
| AU3599701A (en) | Fluorescent probes for the quantitation of zinc | |
| EP1362844A4 (de) | Benzylaminanalogon | |
| DE69901627T2 (de) | Verfahren zur Herstellug von 3-Amino-pyrrolidinderivaten | |
| ATE338057T1 (de) | Peptidderivat, pharmazeutisch unbedenkliches salz davon, verfahren zu dessen herstellung und dessen verwendung | |
| ATE376830T1 (de) | Benzo(b(thiophenderivate und verfahren zu deren herstellung | |
| WO2001072688A3 (fr) | Procede de preparation de la (2s,3r,4s)-4-hydroxyisoleucine et de ses analogues | |
| AU655869B2 (en) | An amphoteric tricyclic compound | |
| ATE289992T1 (de) | Geschützte tyrosinderivate, verfahren zu deren herstellung und deren verwendung zur herstellung von o-(2- ?18 f)-fluorethyl)-l-tyrosin | |
| ATE420067T1 (de) | Peptid-derivate und ihre pharmazeutisch akzeptablensalze, verfahren zur herstellung von beiden und ihre verwendung | |
| EP1005334A4 (de) | Nervenschützende verbindungen und ihre verwendungen | |
| WO2004089962A3 (en) | New carbamoyl-and thiocarbamoyl-phosphonates and pharmaceutical compositions comprising them | |
| ES2149180T3 (es) | Derivado de pirazolotiazolopirimidina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |